Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on April 16, 2025

Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease
BUENOS AIRES, Argentina, April 16, 2025 (GLOBE NEWSWIRE) -- Biosidus, an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has announced encouraging interim results from the Phase III SMILE1 …

Fifth Era Acquisition Corp I Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing April 21, 2025
New York, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Fifth Era Acquisition Corp I (Nasdaq: FERAU) (the “Company”) announced today that, commencing April 21, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade …

ODDITY to Announce First Quarter 2025 Financial Results on April 29, 2025
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its first quarter 2025 financial results after the market close on Tuesday, April 29, 2025, to be followed by a conference call on …

BigCommerce to Announce First Quarter 2025 Financial Results on May 8, 2025
AUSTIN, Texas, April 16, 2025 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced it will report its …

Favorite music sets the brain's opioids in motion
Listening to favorite music affects the function of the brain’s opioid system. TURKU, FINLAND, April 16, 2025 /EINPresswire.com/ -- A new imaging study by the Turku PET Centre in Finland showed that listening to favorite music affects the function of …

Satellogic Announces Closing of $20 Million Registered Direct Offering of Class A Common Stock
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, announced today that it has closed the purchase and sale of 6,451,612 shares of the Company’s Class A Common Stock at a …

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) …

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …

A-Mark Precious Metals Sets Fiscal Third Quarter Earnings Call for Wednesday, May 7th at 4:30 p.m. ET
EL SEGUNDO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on Wednesday, May 7, 2025 at 4:30 p.m. Eastern time to discuss …

Pulmonx to Report First Quarter 2025 Financial Results on April 30, 2025
REDWOOD CITY, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2025 …

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires
BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that …

Bavarian Nordics chikungunyavaccine modtager anbefaling af de amerikanske sundhedsmyndigheders rådgivningskomité (ACIP)
Anbefaling af den første chikungunyavaccine for personer helt ned til 12 år udvider adgangen for amerikanske rejsende til lande med udbrud eller forhøjet risiko for chikungunya. KØBENHAVN, Danmark, 16. april 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte …

Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark, April 16, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today …

Symbotic Announces Date for Reporting Second Quarter Fiscal 2025 Financial Results
WILMINGTON, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced it will release second quarter fiscal 2025 financial results after the market close on …

Eascra Biotech Preparing for a Fifth Flight to the International Space Station
BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech research will be aboard SpaceX 32, scheduled to launch in April, continuing the startup’s ongoing work producing their JBNps (Janus Base Nanoparticles) in space for use in advanced medical …

Olympia Gaming Launches Mobile Apps, LB Rewards and CF Rewards
SAN DIEGO, April 16, 2025 (GLOBE NEWSWIRE) -- Olympia Gaming, the developer of Casino Fandango in Carson City, NV and Legends Bay Casino in Sparks, NV and Quick Custom Intelligence (QCI) today announced the rollout of mobile apps, LB Rewards and CF Rewards …

Global Adhesives and Adhesive-Applying Equipment Market Poised for Steady Growth at 4.5% CAGR
Boston, April 16, 2025 (GLOBE NEWSWIRE) -- BCC Research reveals in its latest study “Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets” the market for adhesives and adhesive-applying equipment is expected to grow from $72.1 billion …

UPDATE - Male Enhancement Procedure by Upsize LLC Surpasses 1,000 Cases, Drives Rapid National Expansion
ROSEVILLE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Upsize LLC, an innovative provider of non-surgical male enhancement treatments, today announced it has successfully performed over 1,000 procedures nationwide, achieving significant growth in just two …

From Service to the Starting Line
TAUNTON, MA, April 16, 2025 (GLOBE NEWSWIRE) -- This April, several Veterans supported by Homes For Our Troops (HFOT) will take on one of the world’s most iconic races—the 2025 Boston Marathon® —running and hand-cycling as part of Team HFOT to raise …

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Pericarditis is an inflammation of the pericardium, the sac-like membrane that surrounds and protects …